The global glaucoma treatment market is projected to grow from USD 5.7 billion in 2022 to USD 8.0 billion by 2033, at a CAGR ...

Glaucoma is one of the leading causes of preventable blindness in the U.S. In general, glaucoma occurs when pressure builds up in the eye and causes damage to the optic nerve. The optic nerve is like ...

And rates are estimated to be even higher by 2033, plus educating caregiver of aging adults on retinal disease and ...

As men reach their 40s ageing can impact vision Regular eye check-ups and healthy habits are key to preventing common eye ...

Maintaining healthy vision and hearing as we age is essential for preserving our quality of life, with regular check-ups and ...

At Beilinson Hospital, we are committed to tackling this issue head-on by embracing the technological revolution in eye care.

More than 4 million people in the U.S. have glaucoma, a group of eye diseases that can damage the optic nerve and lead to ...

SpyGlass Pharma completed enrollment in a Phase 1/2 trial evaluating its drug delivery platform for glaucoma and ocular ...

SpyGlass prepares for End of Phase II meeting with the FDA to advance its Drug Delivery Platform into Phase III pivotal studies; Innovative platform has the potential to enable al ...

OT visited CHEC Watford to hear about how minimally invasive glaucoma surgery is helping patients with mild and moderate levels of the condition ...